Eurofins strengthens its market leadership in the Agro and Feed testing market with the acquisition of BLGG

Eurofins Scientific (EUFI.PA), the global leader in food, environment and pharmaceutical product testing services, announces the acquisition of BLGG Groep BV (BLGG), the leading agribusiness testing service provider in The Netherlands which generates annual revenues in excess of EUR 25m.

BLGG provides innovative testing, sampling and consultancy services, helping agricultural entrepreneurs to improve production quality assurance and efficiency. The laboratory processes more than 500,000 samples per year, and serves approximately 100,000 customers per year, mainly arable farmers, market gardeners, greenhouse horticulturists, cattle farmers, and their suppliers.

Founded in 1928, BLGG has developed an outstanding reputation as a leading service provider to the agricultural sector, both in the Benelux and beyond, empowered by deep agricultural knowledge and innovative reliable analyses. BLGG currently employs more than 250 employees and operates a main laboratory in Wageningen, the Netherlands, but also offers sampling, testing and advisory services in Belgium, Denmark, Germany, Kenya, Morocco, Russia; Spain and Sweden. In the Netherlands and in Spain, BLGG is also operating highly competent pesticide residue laboratories.

Eurofins is active already in agricultural testing and consulting in several countries. BLGG will provide the Group with an even stronger opportunity to accelerate the roll-out of its agricultural testing competence internationally. As part of the Eurofins Group, BLGG will be able to increase its current capabilities to benefit its clients, and expand its market reach. The acquisition also provides BLGG access to an even broader portfolio of high-quality agricultural and food testing services to further strengthen its position as a full agribusiness testing service provider in its markets. Additionally, the BLGG pesticide residue laboratory in Almeria, Spain, but also the laboratory in Wageningen will strengthen the Eurofins footprint in the segment of testing fresh fruits and vegetables in the region of origin.

Comment from Dr. Gilles Martin, Eurofins CEO: "The addition of BLGG into its agricultural testing business reinforces Eurofins' position as leading testing provider to the Agro and Feed industries, expands Eurofins' service offerings and complements our position in the early stages of the food producing industry. BLGG is also an excellent strategic fit with Eurofins' existing activities in and around The Netherlands."

For more information, please visit www.eurofins.com or contact:

Notes for the editor:

Eurofins - a global leader in bio-analysis

Eurofins Scientific is the world leader in food and pharmaceutical products testing. It is also number one in the world in the field of environmental laboratory services and one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services.

With over 14,000 staff in more than 180 laboratories across 35 countries, Eurofins offers a portfolio of over 100,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products. The Group provides its customers with high-quality services, accurate results in time and expert advice by its highly qualified staff.

Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.>

As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.

The shares of Eurofins Scientific are listed on the NYSE Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).

Important disclaimer:

This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific’ management as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the data available to the Company as of the date of publication, but no guarantee can be made as to their validity.